Ping Cheng
7PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jan 29, 2026
SAMHD1 drives immunosuppression in non-small cell lung cancer by promoting macrophage infiltration and restricting oncolytic adenovirus replication.Shichuan Hu, Jian Xu, Zhiwu Wang
|Nov 25, 2025
Endoplasmic reticulum stress-driven LncRNA signature predicts cervical cancer prognosis and guides personalized immunotherapy: a multi-omics and functional validation study.Jianchuan Hu, Zhongbing Qi, Shichuan Hu
|Dec 04, 2024
Mitochondrial metabolic reprogramming of macrophages and T cells enhances CD47 antibody-engineered oncolytic virus antitumor immunity.Jing Zhao, Shichuan Hu, Zhongbing Qi
|Feb 05, 2022
Long noncoding RNA RP11-241J12.3 targeting pyruvate carboxylase promotes hepatocellular carcinoma aggressiveness by disrupting pyruvate metabolism and the DNA mismatch repair system.Liuliu Cheng, Shichuan Hu, Jinhu Ma
|Aug 18, 2021
Antifibrotic Therapy Augments the Antitumor Effects of Vesicular Stomatitis Virus Via Reprogramming Tumor Microenvironment.Yanwei Chen, Shichuan Hu, Yongheng Shu
|Dec 18, 2020
Hepatic stellate cells specific liposomes with the Toll-like receptor 4 shRNA attenuates liver fibrosis.Yuwei Zhang, Yang Li, Tong Mu
Pageof 2
